Investment Rating - The report maintains a "Buy" rating for the company, expecting a relative increase in stock price of over 20% compared to the benchmark index within six months [9][15]. Core Insights - The company has invested in Star Ring Fusion, supporting the development of controllable nuclear fusion technology, with a total investment of 1 billion yuan in the A-round financing [4]. - Star Ring Fusion, established in October 2021, is based on Tsinghua University's technology and aims to complete engineering validation by 2028 and start commercial demonstration by around 2032 [5]. - The company is a leader in the tank container industry, holding approximately 50% of the global market share, and is actively exploring new business opportunities in high-end equipment and medical imaging sectors [6]. Financial Performance and Projections - The company’s projected revenues for 2025, 2026, and 2027 are 2.725 billion yuan, 3.998 billion yuan, and 4.916 billion yuan, respectively, with expected growth rates of -18.62%, 46.69%, and 22.97% [7][11]. - The forecasted net profit attributable to the parent company for the same years is 169 million yuan, 308 million yuan, and 449 million yuan, with growth rates of -44.48%, 82.34%, and 45.93% [9][11]. - The corresponding price-to-earnings ratios (P/E) are projected to be 65.62, 35.99, and 24.66 for the years 2025, 2026, and 2027 [9][11].
中集环科（301559）：投资星环聚能，助力可控核聚变事业发展